EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)Multizentrische StudieOpen Access · CC BY 4.0

Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial

Lucrezia Laterza iD, Cesare Cremon iD, Gaetano Coppola, Carlo Romano Settanni, Rossella Maresca iD, Martina Strazzeri, Eleonora Durini, Valentina Petito, Franco Scaldaferri iD, Giorgio Gargari iD, Diego Mora iD, Elnaz Vojoudi Yazdi und 7 weitere

Nutrients · 18.05.2025 · 17 (10) · 1708

DOI: 10.3390/nu17101708 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 18.05.2025. Verfasst von Lucrezia Laterza und 18 weiteren Autor:innen. Beteiligte Einrichtung: CEMAD Digestive Disease Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Probiotics, Irritable Bowel Syndrome, Vitamin D. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beingpharma, Beingpharma Srl (Italy).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The disruption of the intestinal barrier and the imbalance of the gut microbiota (GM) seem to play a major role in the complex pathogenesis of irritable bowel syndrome (IBS). Specific microbial strains could improve the gut microenvironment, promoting anti-inflammatory pathways; similarly, vitamin D supplementation could play a role in enhancing the barrier integrity and modulating the immune response in the gut. This study aims to evaluate the efficacy of a new multistrain probiotic, combined with vitamin D, in improving gut barrier function in IBS without constipation.

Methods

In this phase IIb double-blind randomized placebo-controlled, parallel-group, multicenter, clinical trial, 35 patients were treated for 12 weeks with OttaBac®, a high concentration multistrain probiotic plus cholecalciferol, or placebo and were followed up until week 16. Symptoms, quality of life, intestinal permeability, fecal biomarkers, and microbiota composition were evaluated at 0, 12, and 16 weeks.

Results

Mean zonulin values showed a significant progressive reduction in the active group (−10.2 ng/mL at week 12, p = 0.0375; −19.5 ng/mL at week 16, p = 0.0002), with a significant difference between groups at week 16 in the per-protocol population (−19.01, p = 0.0053). The active group showed a more stable trend toward improvement in stool frequency and consistency at both week 12 and 16, with a significant improvement compared to the baseline and to the placebo group (−23.2, p = 0.0265, and 5.57 vs. −23.2, p = 0.0492, respectively). No differences were found in regards to the lactulose/mannitol ratio, Irritable Bowel Syndrome Severity Scoring System (IBS-SSS) and Short Form Health Survey (SF-36) total scores, plasmalemmal vesicle associated protein-1 (PV-1), and citrulline levels. In the active group, Bifidobacterium animalis subsp. lactis and Streptococcus thermophilus levels were increased (p < 0.05), while those for Lachnospira were decreased (p < 0.05), and significant changes in Actinobacteria and Proteobacteria were observed (p < 0.05). Lactate (p < 0.01) and acetate (p < 0.05) levels increased post-treatment. Correlation analysis pointed out a significant association between the microbial biomarkers and the symptoms (p < 0.05).

Conclusions

Probiotic plus vitamin D could improve IBS-associated symptoms through gut microbiota modulation and gut barrier enhancement, with persistent benefits after treatment discontinuation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeProbioticsIrritable Bowel SyndromeVitamin DIntestinal MucosaCholecalciferolHumansDouble-Blind MethodMaleFemaleAdultMiddle AgedFecesTreatment OutcomePermeabilityQuality of LifeConstipationHaptoglobinsProtein Precursors

Stichwörter der Autor:innen

IBSgut barrierprobiotic

Substanzen

Vitamin DzonulinCholecalciferolHaptoglobinsProtein Precursors

Autor:innen und Institutionen

  • CEMAD Digestive Disease Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
  • Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168 Rome, Italy.
  • Department of Medical and Surgical Sciences, University of Bologna, 40100 Bologna, Italy.
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40100 Bologna, Italy.
  • Unit of Gastroenterology and Digestive Endoscopy, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) Italian National Research Centres on Aging (INRCA), 60100 Ancona, Italy.
  • CeMAD Translational Research Laboratories, Digestive Disease Center (CeMAD), Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, 00146 Rome, Italy.

ORCID-Profile: Lucrezia Laterza, Cesare Cremon, Rossella Maresca, Franco Scaldaferri, Giorgio Gargari, Diego Mora, Chiara Marangelo, Lorenza Putignani, Giovanni Marasco, Antonio Gasbarrini

Förderung

  • Beingpharma
  • Beingpharma Srl (Italy)

Zitieren

APA

Laterza, L., Cremon, C., Coppola, G., Settanni, C. R., Maresca, R., Strazzeri, M., Durini, E., Petito, V., Scaldaferri, F., Gargari, G., Mora, D., Vojoudi Yazdi, E., Marangelo, C., Ianiro, G., Putignani, L., Barbaro, M. R., Marasco, G., Barbara, G., & Gasbarrini, A. (2025). Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial. Nutrients, 17(10), 1708. https://doi.org/10.3390/nu17101708

Vancouver

Laterza L, Cremon C, Coppola G, Settanni CR, Maresca R, Strazzeri M, et al. Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial. Nutrients. 2025;17(10):1708. doi:10.3390/nu17101708

BibTeX
@article{Laterza2025,
  author = {Laterza, Lucrezia and Cremon, Cesare and Coppola, Gaetano and Settanni, Carlo Romano and Maresca, Rossella and Strazzeri, Martina and Durini, Eleonora and Petito, Valentina and Scaldaferri, Franco and Gargari, Giorgio and Mora, Diego and Vojoudi Yazdi, Elnaz and Marangelo, Chiara and Ianiro, Gianluca and Putignani, Lorenza and Barbaro, Maria Raffaella and Marasco, Giovanni and Barbara, Giovanni and Gasbarrini, Antonio},
  title = {Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {10},
  pages = {1708},
  doi = {10.3390/nu17101708}
}
Kostenlos starten →